| Three months of rifapentine and isoniazid for latent tuberculosis infection TR Sterling, ME Villarino, AS Borisov, N Shang, F Gordin, ... New England Journal of Medicine 365 (23), 2155-2166, 2011 | 1130 | 2011 |
| Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans DR Velez, C Wejse, ME Stryjewski, E Abbate, WF Hulme, JL Myers, ... Human genetics 127, 65-73, 2010 | 200 | 2010 |
| Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia B Cao, H Gao, B Zhou, X Deng, C Hu, C Deng, H Lu, Y Li, J Gan, J Liu, ... Critical care medicine 44 (6), e318-e328, 2016 | 184 | 2016 |
| Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults—seven African countries, 2004–2013 AF Auld, SG Agolory, RW Shiraishi, F Wabwire-Mangen, G Kwesigabo, ... MMWR Morb Mortal Wkly Rep 63 (47), 1097-103, 2014 | 138 | 2014 |
| Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection DP Holland, GD Sanders, CD Hamilton, JE Stout American journal of respiratory and critical care medicine 179 (11), 1055-1060, 2009 | 136 | 2009 |
| Synergistic pandemics: confronting the global HIV and tuberculosis epidemics KH Mayer, CD Hamilton Clinical Infectious Diseases 50 (Supplement_3), S67-S70, 2010 | 121 | 2010 |
| Infectious complications of treatment with biologic agents CD Hamilton Current opinion in rheumatology 16 (4), 393-398, 2004 | 113 | 2004 |
| Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid or daily isoniazid for treatment of latent tuberculosis infection in the … TR Sterling, RN Moro, AS Borisov, E Phillips, G Shepherd, NF Adkinson, ... Clinical Infectious Diseases 61 (4), 527-535, 2015 | 110 | 2015 |
| NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans DR Velez, WF Hulme, JL Myers, JB Weinberg, MC Levesque, ... Human genetics 126, 643-653, 2009 | 106 | 2009 |
| Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis JE Stout, JJ Engemann, AC Cheng, ER Fortenberry, CD Hamilton American journal of respiratory and critical care medicine 167 (6), 824-827, 2003 | 95 | 2003 |
| A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment NN Bock, TR Sterling, CD Hamilton, C Pachucki, YC Wang, DS Conwell, ... American journal of respiratory and critical care medicine 165 (11), 1526-1530, 2002 | 95 | 2002 |
| Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis KE Dooley, CD Mitnick, M Ann DeGroote, E Obuku, V Belitsky, ... Clinical infectious diseases 55 (4), 572-581, 2012 | 80 | 2012 |
| Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1–infected infant VA Johnson, CJ Petropoulos, CR Woods, JD Hazelwood, NT Parkin, ... The Journal of infectious diseases 183 (11), 1688-1693, 2001 | 80 | 2001 |
| Tuberculosis in the cytokine era: what rheumatologists need to know CD Hamilton Arthritis & Rheumatism: Official Journal of the American College of …, 2003 | 79 | 2003 |
| A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution MD Johnson, CD Hamilton, RH Drew, LL Sanders, GJ Pennick, JR Perfect Journal of Antimicrobial Chemotherapy 51 (2), 453-457, 2003 | 77 | 2003 |
| Current issues in global tuberculosis control R Frothingham, JE Stout, CD Hamilton International journal of infectious diseases 9 (6), 297-311, 2005 | 75 | 2005 |
| Antiretroviral therapy effects on genetic and morphologic end points in lymphocytes and sperm of men with human immunodeficiency virus infection WA Robbins, KL Witt, JK Haseman, DB Dunson, L Troiani, MS Cohen, ... The Journal of infectious diseases 184 (2), 127-135, 2001 | 70 | 2001 |
| The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection AS Dobs, J Cofrancesco, WE Nolten, A Danoff, R Anderson, CD Hamilton, ... The American journal of medicine 107 (2), 126-132, 1999 | 70 | 1999 |
| Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians DR Velez, WF Hulme, JL Myers, ME Stryjewski, E Abbate, R Estevan, ... The International Journal of Tuberculosis and Lung Disease 13 (9), 1068-1076, 2009 | 68 | 2009 |
| Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection DP Holland, CD Hamilton, AC Weintrob, JJ Engemann, ER Fortenberry, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (5 …, 2009 | 68 | 2009 |
